Filing Details
- Accession Number:
- 0000890465-14-000036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-14 20:35:54
- Reporting Period:
- 2014-02-12
- Filing Date:
- 2014-02-14
- Accepted Time:
- 2014-02-14 20:35:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
890465 | Nps Pharmaceuticals Inc | NPSP | Biological Products, (No Disgnostic Substances) (2836) | 870439579 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1013420 | G James Groninger | 550 Hills Drive Bedminster NJ 07921 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-13 | 15,188 | $0.00 | 15,938 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-13 | 6,000 | $37.70 | 9,938 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Acquisiton | 2014-02-12 | 4,572 | $0.00 | 4,572 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2014-02-13 | 15,188 | $0.00 | 15,188 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,572 | No | 4 | A | Direct | ||
0 | No | 4 | M | Direct |
Footnotes
- Each vested Restricted Stock Unit was the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2013.
- Each Restricted Stock Unit was awarded under the Issuer's amended and restated 2005 Omnibus Incentive Plan and represents a contingent right to receive one share of the Issuer's common stock.
- One hundred percent of the Restricted Stock Units will vest on the first anniversary of the date of grant. Vested shares will be delivered to the Reporting Person as soon as administratively practicable following the vesting of the Restricted Stock Units.
- On February 13, 2013, the Restricted Stock Units were granted with one hundred percent of such Restricted Stock Units vesting on the first anniversary of the date of grant. As of the date of this filing, all of the Restricted Stock Units have vested.